Health
U.K. says study supports delaying 2nd COVID-19 vaccine dose – Los Angeles Times
A study finds that the AstraZeneca-Oxford University vaccine cut coronavirus transmission by two-thirds and prevented COVID-19.
Britains health chief has hailed a new study suggesting that a single dose of the Oxford-AstraZeneca COVID-19 vaccine provides a high level of protection for 12 weeks, saying it supports the governments contentious strategy of delaying the second shot so it can protect more people quickly with a first dose.
Britains decision has been criticized as risky by other European countries, but Health Secretary Matt Hancock said Wednesday that the study backs the strategy that weve taken, and it shows the…
-
Noosa News24 hours agoTrucking company penalised for refusing to pay unfairly sacked worker
-
Noosa News7 hours agoJessica Alba spotted filming spy thriller on the Gold Coast as cameras roll under iconic bridge
-
Noosa News19 hours agoTallest tower outside CBD approved for construction at 205 metres
-
Noosa News20 hours agoFarmgate Backpackers leads with integrity amid industry challenges